These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21167391)

  • 1. γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.
    Lin J; Zhang XM; Yang JC; Ye YB; Luo SQ
    Arch Med Res; 2010 Oct; 41(7):519-29. PubMed ID: 21167391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
    Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer.
    Mizugaki H; Sakakibara-Konishi J; Ikezawa Y; Kikuchi J; Kikuchi E; Oizumi S; Dang TP; Nishimura M
    Br J Cancer; 2012 Jun; 106(12):1953-9. PubMed ID: 22596234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells.
    Tanaka S; Nakada M; Yamada D; Nakano I; Todo T; Ino Y; Hoshii T; Tadokoro Y; Ohta K; Ali MA; Hayashi Y; Hamada J; Hirao A
    J Neurooncol; 2015 Jan; 121(2):239-50. PubMed ID: 25293440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
    Li ZL; Chen C; Yang Y; Wang C; Yang T; Yang X; Liu SC
    Int J Clin Exp Pathol; 2015; 8(5):4378-87. PubMed ID: 26191129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor.
    Jin F; Gao C; Zhao L; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Jiang XB; Zhou YP; Zhao HY
    Brain Res; 2011 Jan; 1368():82-90. PubMed ID: 20971095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.
    Yang L; Zhang S; George SK; Teng R; You X; Xu M; Liu H; Sun X; Amin HM; Shi W
    Oncotarget; 2015 Jun; 6(17):14953-69. PubMed ID: 25879451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
    Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
    Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch promotes radioresistance of glioma stem cells.
    Wang J; Wakeman TP; Lathia JD; Hjelmeland AB; Wang XF; White RR; Rich JN; Sullenger BA
    Stem Cells; 2010 Jan; 28(1):17-28. PubMed ID: 19921751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.
    Meng X; Matlawska-Wasowska K; Girodon F; Mazel T; Willman CL; Atlas S; Chen IM; Harvey RC; Hunger SP; Ness SA; Winter SS; Wilson BS
    Leukemia; 2011 Jul; 25(7):1135-46. PubMed ID: 21494254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
    Wang L; Long L; Wang W; Liang Z
    J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets.
    Dorneburg C; Goß AV; Fischer M; Roels F; Barth TF; Berthold F; Kappler R; Oswald F; Siveke JT; Molenaar JJ; Debatin KM; Beltinger C
    Oncotarget; 2016 Sep; 7(39):62799-62813. PubMed ID: 27588497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
    Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
    Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Notch signaling pathway enhanced the radiosensitivity of breast cancer cells.
    Peng JH; Wang XL; Ran L; Song JL; Zhang ZT; Liu X; Li HY
    J Cell Biochem; 2018 Nov; 119(10):8398-8409. PubMed ID: 29904942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.